Biotech | February 23, 2022
Merck completes acquisition of biopharma CDMO Exelead
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
He will continue to lead business in LATAM and Asia regions in this new role
The RTP manufacturing facility will support the company's clinical studies and early commercial launch in North America and Europe
The facility will manufacture its Herceptin biosimilar, Tuznue
New inhalers would have near-zero Global Warming Potential propellant
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
The transaction as well as the open offer is expected to be completed by June this year.
The facility will cater to the storage, handling and transportation of pharma, dairy products seafood among others
Subscribe To Our Newsletter & Stay Updated
